JP2003528880A5 - - Google Patents

Download PDF

Info

Publication number
JP2003528880A5
JP2003528880A5 JP2001570667A JP2001570667A JP2003528880A5 JP 2003528880 A5 JP2003528880 A5 JP 2003528880A5 JP 2001570667 A JP2001570667 A JP 2001570667A JP 2001570667 A JP2001570667 A JP 2001570667A JP 2003528880 A5 JP2003528880 A5 JP 2003528880A5
Authority
JP
Japan
Prior art keywords
carbons
carbon atoms
alkyl
embedded image
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001570667A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003528880A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2001/010124 external-priority patent/WO2001072758A1/en
Publication of JP2003528880A publication Critical patent/JP2003528880A/ja
Publication of JP2003528880A5 publication Critical patent/JP2003528880A5/ja
Pending legal-status Critical Current

Links

JP2001570667A 2000-03-28 2001-03-28 三環系タンパクキナーゼ阻害薬 Pending JP2003528880A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US53691900A 2000-03-28 2000-03-28
US09/536,919 2000-03-28
PCT/US2001/010124 WO2001072758A1 (en) 2000-03-28 2001-03-28 Tricyclic protein kinase inhibitors

Publications (2)

Publication Number Publication Date
JP2003528880A JP2003528880A (ja) 2003-09-30
JP2003528880A5 true JP2003528880A5 (cg-RX-API-DMAC7.html) 2008-05-22

Family

ID=24140461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001570667A Pending JP2003528880A (ja) 2000-03-28 2001-03-28 三環系タンパクキナーゼ阻害薬

Country Status (11)

Country Link
EP (1) EP1268487B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003528880A (cg-RX-API-DMAC7.html)
CN (1) CN100369919C (cg-RX-API-DMAC7.html)
AR (1) AR028261A1 (cg-RX-API-DMAC7.html)
AT (1) ATE255114T1 (cg-RX-API-DMAC7.html)
AU (1) AU2001247882A1 (cg-RX-API-DMAC7.html)
BR (1) BR0109598A (cg-RX-API-DMAC7.html)
CA (1) CA2404445A1 (cg-RX-API-DMAC7.html)
DE (1) DE60101323T2 (cg-RX-API-DMAC7.html)
MX (1) MXPA02009440A (cg-RX-API-DMAC7.html)
WO (1) WO2001072758A1 (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002352878B2 (en) 2001-11-27 2007-11-22 Merck Sharp & Dohme Corp. 2-Aminoquinoline compounds
TWI329105B (en) 2002-02-01 2010-08-21 Rigel Pharmaceuticals Inc 2,4-pyrimidinediamine compounds and their uses
ES2421139T3 (es) 2003-07-30 2013-08-29 Rigel Pharmaceuticals, Inc. Compuestos de 2,4-pirimidindiamina para su uso en el tratamiento o la prevención de enfermedades autoinmunitarias
AU2005231507B2 (en) 2004-04-08 2012-03-01 Targegen, Inc. Benzotriazine inhibitors of kinases
US20070203161A1 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
WO2006133426A2 (en) 2005-06-08 2006-12-14 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
WO2007053452A1 (en) 2005-11-01 2007-05-10 Targegen, Inc. Bi-aryl meta-pyrimidine inhibitors of kinases
WO2007098507A2 (en) 2006-02-24 2007-08-30 Rigel Pharmaceuticals, Inc. Compositions and methods for inhibition of the jak pathway
CA2699349C (en) * 2007-09-14 2016-04-19 Bayer Schering Pharma Aktiengesellschaft Substituted tricyclic heterocyclic compounds for use as egfr inhibitors
HRP20170317T1 (hr) 2008-02-15 2017-04-21 Rigel Pharmaceuticals, Inc. Spojevi pirimidin-2-amina i njihova uporaba kao inhibitora jak kinaza
US8138339B2 (en) 2008-04-16 2012-03-20 Portola Pharmaceuticals, Inc. Inhibitors of protein kinases
US8063058B2 (en) 2008-04-16 2011-11-22 Portola Pharmaceuticals, Inc. Inhibitors of syk and JAK protein kinases
BRPI0910668A2 (pt) 2008-04-22 2019-09-24 Portola Pharmaceutiacals Inc inibidores de proteína quinases
SG187064A1 (en) * 2010-07-14 2013-02-28 Zhejiang Beta Pharma Inc NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
EP2975027A1 (en) 2010-11-01 2016-01-20 Portola Pharmaceuticals, Inc. Nicotinamides as jak kinase modulators
AU2010363329A1 (en) 2010-11-07 2013-05-09 Targegen, Inc. Compositions and methods for treating myelofibrosis
EP2782579B1 (en) 2011-11-23 2019-01-02 Portola Pharmaceuticals, Inc. Pyrazine kinase inhibitors
WO2014058921A2 (en) 2012-10-08 2014-04-17 Portola Pharmaceuticals, Inc. Substituted pyrimidinyl kinase inhibitors
CA3129665A1 (en) 2019-03-21 2020-09-24 Onxeo A dbait molecule in combination with kinase inhibitor for the treatment of cancer
US12523663B2 (en) 2019-06-04 2026-01-13 Inserm (Institut National De La Santé Et De La Rescherche Médicale) Use of CD9 as a biomarker and as a biotarget in glomerulonephritis or glomerulosclerosis
KR20220098759A (ko) 2019-11-08 2022-07-12 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) 키나제 억제제에 대해 내성을 획득한 암의 치료 방법
WO2021148581A1 (en) 2020-01-22 2021-07-29 Onxeo Novel dbait molecule and its use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2712290A1 (fr) * 1993-11-10 1995-05-19 Pf Medicament Oxazino-acridines substituées, leur préparation et leur application en thérapeutique.
US6002008A (en) * 1997-04-03 1999-12-14 American Cyanamid Company Substituted 3-cyano quinolines

Similar Documents

Publication Publication Date Title
JP2024508235A (ja) 三環-アミド-二環prmt5阻害剤
JP2005504080A5 (cg-RX-API-DMAC7.html)
RU2006147237A (ru) Производные пирролотриазина, применение для лечения гиперпролиферативных нарушений и заболеваний, связанных с ангиогенезом
CA3028997A1 (en) 2,4-diamino-pyrimidine compounds and method for making and using the compounds
RU2018134981A (ru) Конъюгаты, содержащие ингибиторы RIPK2
CN108366992A (zh) 蛋白水解靶向嵌合体化合物及其制备和应用方法
JP2003511384A5 (cg-RX-API-DMAC7.html)
RU2003116061A (ru) Тиоэфирзамещенные имидазохинолины
US20200331891A9 (en) 2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation method and use thereof
WO2007109334B1 (en) Sip receptor modulating compounds and use thereof
JP6554538B2 (ja) 未分化リンパ腫キナーゼの多環状阻害剤
CA2545527A1 (en) Pyrazole derivatives as inhibitors of receptor tyrosyne kinases
JP2012520269A5 (cg-RX-API-DMAC7.html)
JP5901634B2 (ja) キナゾリン化合物及びその使用方法
RU2005122901A (ru) Производные пиридино [2,3-] пиримидина в качестве селективных ингибиторов kdr и fgfr
JP2004525965A5 (cg-RX-API-DMAC7.html)
JP2005508953A5 (cg-RX-API-DMAC7.html)
JP2017501983A5 (cg-RX-API-DMAC7.html)
ES2939232T3 (es) Derivados de oxazol para uso como inhibidores de IRAK y método para su preparación
RU2012120901A (ru) Способ лечения пролиферативных расстройств и других патологических состояний, опосредованных действием киназ bcr-abl, c-kit, ddr1, ddr2 или pdgf-r
JP2012518598A5 (cg-RX-API-DMAC7.html)
AU2001232238B2 (en) Anti-acid-fast bacterial agents containing pyridonecarboxylic acids as the active ingredient
WO2001072758A1 (en) Tricyclic protein kinase inhibitors
AU2021300831A1 (en) RIP1k inhibitors
JP6250062B2 (ja) がん、ウイルス感染症、及び肺疾患の処置のためのインドールの新規誘導体